{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:52:00Z","timestamp":1790268720610,"version":"4.1.0"},"reference-count":179,"publisher":"Bentham Science Publishers Ltd.","issue":"23","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,10,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Privileged motifs are recurring in a wide range of biologically\nactive compounds that reach different pharmaceutical targets and pathways and could represent\na suitable start point to access potential candidates in the neglected diseases field.\nThe current therapies to treat these diseases are based in drugs that lack of the desired effectiveness,\naffordable methods of synthesis and allow a way to emergence of resistant\nstrains. Due the lack of financial return, only few pharmaceutical companies have been\ninvesting in research for new therapeutics for neglected diseases (ND).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Based on the literature search from 2002 to 2016, we discuss how six privileged\nmotifs, focusing phthalimide, isatin, indole, thiosemicarbazone, thiazole, and thiazolidinone\nare particularly recurrent in compounds active against some of neglected diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>It was observed that attention was paid particularly for Chagas disease, malaria,\ntuberculosis, schistosomiasis, leishmaniasis, dengue, African sleeping sickness (Human\nAfrican Trypanosomiasis - HAT) and toxoplasmosis. It was possible to verify that, among\nthe ND, antitrypanosomal and antiplasmodial activities were between the most searched.\nBesides, thiosemicarbazone moiety seems to be the most versatile and frequently explored\nscaffold. As well, phthalimide, isatin, thiazole, and thiazolidone nucleus have been also\nexplored in the ND field.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Some described compounds, appear to be promising drug candidates, while\nothers could represent a valuable inspiration in the research for new lead compounds.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867324666171023163752","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T15:11:55Z","timestamp":1570720315000},"page":"4323-4354","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Privileged Structures in the Design of Potential Drug Candidates for Neglected Diseases"],"prefix":"10.2174","volume":"26","author":[{"given":"Ana Cristina  Lima","family":"Leite","sequence":"first","affiliation":[{"name":"Departamento de Ciencias Farmaceuticas, Centro de Ciencias da Saude, Universidade Federal de Pernambuco, 50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Wanderlan Pontes","family":"Esp\u00edndola","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Farmaceuticas, Centro de Ciencias da Saude, Universidade Federal de Pernambuco, 50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Ver\u00edssimo","family":"de Oliveira Cardoso","sequence":"additional","affiliation":[{"name":"Colegiado de Nutricao, Campus Petrolina, Universidade de Pernambuco, 56328-903, Petrolina, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gevanio Bezerra","family":"de Oliveira Filho","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Farmaceuticas, Centro de Ciencias da Saude, Universidade Federal de Pernambuco, 50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1517\/17460441.2011.550914","volume":"6","author":"Bongarzone S.","year":"2011","unstructured":"Bongarzone S.; Bolognesi M.L.; The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases. Expert Opin Drug Discov 2011,6(3),251-268","journal-title":"Expert Opin Drug Discov"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1021\/jm00120a002","volume":"31","author":"Evans B.E.","year":"1988","unstructured":"Evans B.E.; Rittle K.E.; Bock M.G.; DiPardo R.M.; Freidinger R.M.; Whitter W.L.; Lundell G.F.; Veber D.F.; Anderson P.S.; Chang R.S.; Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem 1988,31(12),2235-2246","journal-title":"J Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/cr020033s","volume":"103","author":"Horton D.A.","year":"2003","unstructured":"Horton D.A.; Bourne G.T.; Smythe M.L.; The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 2003,103(3),893-930","journal-title":"Chem Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/092986706775197999","volume":"13","author":"Costantino L.","year":"2006","unstructured":"Costantino L.; Barlocco D.; Privileged structures as leads in medicinal chemistry. Curr Med Chem 2006,13(1),65-85","journal-title":"Curr Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1386207043328544","volume":"7","author":"DeSimone R.W.","year":"2004","unstructured":"DeSimone R.W.; Currie K.S.; Mitchell S.A.; Darrow J.W.; Pippin D.A.; Privileged structures: applications in drug discovery. Comb Chem High Throughput Screen 2004,7(5),473-494","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2174\/092986712800167356","volume":"19","author":"Polanski J.","year":"2012","unstructured":"Polanski J.; Kurczyk A.; Bak A.; Musiol R.; Privileged structures - dream or reality: preferential organization of azanaphthalene scaffold. Curr Med Chem 2012,19(13),1921-1945","journal-title":"Curr Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drudis.2014.09.023","volume":"20","author":"Goldberg F.W.","year":"2015","unstructured":"Goldberg F.W.; Kettle J.G.; Kogej T.; Perry M.W.; Tomkinson N.P.; Designing novel building blocks is an overlooked strategy to improve compound quality. Drug Discov Today 2015,20(1),11-17","journal-title":"Drug Discov Today"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drudis.2014.09.015","volume":"20","author":"Chen H.","year":"2015","unstructured":"Chen H.; Zhou X.; Wang A.; Zheng Y.; Gao Y.; Zhou J.; Evolutions in fragment-based drug design: the deconstruction-reconstruction approach. Drug Discov Today 2015,20(1),105-113","journal-title":"Drug Discov Today"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrd3926-c1","volume":"12","author":"Jhoti H.","year":"2013","unstructured":"Jhoti H.; Williams G.; Rees D.C.; Murray C.W.; The \u2018rule of three\u2019 for fragment-based drug discovery: where are we now? Nat Rev Drug Discov 2013,12(8),644-645","journal-title":"Nat Rev Drug Discov"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","volume":"8","author":"Congreve M.","year":"2003","unstructured":"Congreve M.; Carr R.; Murray C.; Jhoti H.A.; \u2018rule of three\u2019 for fragment-based lead discovery? Drug Discov Today 2003,8(19),876-877","journal-title":"Drug Discov Today"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/0929867321666141106122628","volume":"22","author":"Guzior N.","year":"2015","unstructured":"Guzior N.; Wieckowska A.; Panek D.; Malawska B.; Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease. Curr Med Chem 2015,22(3),373-404","journal-title":"Curr Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1021\/jm058225d","volume":"48","author":"Morphy R.","year":"2005","unstructured":"Morphy R.; Rankovic Z.; Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem 2005,48(21),6523-6543","journal-title":"J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2174\/138161209787315594","volume":"15","author":"Morphy R.","year":"2009","unstructured":"Morphy R.; Rankovic Z.; Designing multiple ligands - medicinal chemistry strategies and challenges. Curr Pharm Des 2009,15(6),587-600","journal-title":"Curr Pharm Des"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bmc.2005.09.011","volume":"14","author":"Espinoza-Fonseca L.M.","year":"2006","unstructured":"Espinoza-Fonseca L.M.; The benefits of the multi-target approach in drug design and discovery. Bioorg Med Chem 2006,14(4),896-897","journal-title":"Bioorg Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/11597630-000000000-00000","volume":"26","author":"M\u00fcller-Schiffmann A.","year":"2012","unstructured":"M\u00fcller-Schiffmann A.; Sticht H.; Korth C.; Hybrid compounds: from simple combinations to nanomachines. BioDrugs 2012,26(1),21-31","journal-title":"BioDrugs"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejmech.2014.12.039","volume":"92","author":"Alanazi A.M.","year":"2015","unstructured":"Alanazi A.M.; El-Azab A.S.; Al-Suwaidan I.A.; ElTahir K.E.; Asiri Y.A.; Abdel-Aziz N.I.; Abdel-Aziz A.A.; Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities. Eur J Med Chem 2015,92,115-123","journal-title":"Eur J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1016\/j.ejmech.2011.07.043","volume":"46","author":"Kami\u0144ski K.","year":"2011","unstructured":"Kami\u0144ski K.; Obniska J.; Wiklik B.; Atamanyuk D.; Synthesis and anticonvulsant properties of new acetamide derivatives of phthalimide, and its saturated cyclohexane and norbornene analogs. Eur J Med Chem 2011,46(9),4634-4641","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1016\/j.bmc.2012.04.060","volume":"20","author":"Akg\u00fcn H.","year":"2012","unstructured":"Akg\u00fcn H.; Karameleko\u011flu I.; Berk B.; Kurnaz I.; Sar\u0131b\u0131y\u0131k G.; \u00d6ktem S.; Kocag\u00f6z T.; Synthesis and antimycobacterial activity of some phthalimide derivatives. Bioorg Med Chem 2012,20(13),4149-4154","journal-title":"Bioorg Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1016\/j.ejmech.2011.07.002","volume":"46","author":"Abdel-Aziz A.A.","year":"2011","unstructured":"Abdel-Aziz A.A.; El-Azab A.S.; Attia S.M.; Al-Obaid A.M.; Al-Omar M.A.; El-Subbagh H.I.; Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents. Eur J Med Chem 2011,46(9),4324-4329","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00044-013-0730-1","volume":"23","author":"Leite A.C.L.","year":"2014","unstructured":"Leite A.C.L.; Barbosa F.F.; Phthaloyl amino acids as anti-inflammatory and immunomodulatory prototypes. Med Chem Res 2014,23,1701-1708","journal-title":"Med Chem Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ica.2015.01.011","volume":"427","author":"Singh G.","year":"2015","unstructured":"Singh G.; Saroa A.; Girdhar S.; Rani S.; Sahoo S.; Choquesillo-Lazarte D.; Synthesis, characterization, electronic absorption and antimicrobial studies of N-(silatranylpropyl)phthalimide derived from phthalic anhydride. Inorg Chim Acta 2015,427,232-239","journal-title":"Inorg Chim Acta"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijcas.2013.04.004","volume":"4","author":"Elumalai K.","year":"2013","unstructured":"Elumalai K.; Ali M.A.; Elumalai M.; Eluri K.; Srinivasan S.; Sivannan S.; Synthesis, characterization and biological evaluation of acetazolamide, cycloserine and isoniazid condensed some novel phthalimide derivatives. Int J Chem Anal Sci 2013,4,57-61","journal-title":"Int J Chem Anal Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bmcl.2011.01.044","volume":"21","author":"Williams R.","year":"2011","unstructured":"Williams R.; Manka J.T.; Rodriguez A.L.; Vinson P.N.; Niswender C.M.; Weaver C.D.; Jones C.K.; Conn P.J.; Lindsley C.W.; Stauffer S.R.; Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold. Bioorg Med Chem Lett 2011,21(5),1350-1353","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejmech.2015.04.041","volume":"96","author":"Cardoso M.V.","year":"2015","unstructured":"Cardoso M.V.; Moreira D.R.; Oliveira Filho G.B.; Cavalcanti S.M.; Coelho L.C.; Esp\u00edndola J.W.; Gonzalez L.R.; Rabello M.M.; Hernandes M.Z.; Ferreira P.M.; Pessoa C.; Alberto de Simone C.; Guimar\u00e3es E.T.; Soares M.B.; Leite A.C.; Design, synthesis and structure-activity relationship of phthalimides endowed with dual antiproliferative and immunomodulatory activities. Eur J Med Chem 2015,96,491-503","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1039\/C4MD00070F","volume":"5","author":"Co\u00ealho L.C.D.","year":"2014","unstructured":"Co\u00ealho L.C.D.; Novel phthalimide derivatives with TNF-\u03b1 and IL-1\u03b2 expression inhibitory and apoptotic inducing properties. MedChemComm 2014,5,758","journal-title":"MedChemComm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cbi.2015.06.037","volume":"239","author":"da Costa P.M.","year":"2015","unstructured":"da Costa P.M.; da Costa M.P.; Carvalho A.A.; Cavalcanti S.M.; de Oliveira Cardoso M.V.; de Oliveira Filho G.B.; de Ara\u00fajo Viana D.; Fechine-Jamacaru F.V.; Leite A.C.; de Moraes M.O.; Pessoa C.; Ferreira P.M.; Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives. Chem Biol Interact 2015,239,174-183","journal-title":"Chem Biol Interact"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1016\/j.bmcl.2005.07.046","volume":"15","author":"Bal T.R.","year":"2005","unstructured":"Bal T.R.; Anand B.; Yogeeswari P.; Sriram D.; Synthesis and evaluation of anti-HIV activity of isatin \u03b2-thiosemicarbazone derivatives. Bioorg Med Chem Lett 2005,15(20),4451-4455","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.bmcl.2006.01.066","volume":"16","author":"Jiang T.","year":"2006","unstructured":"Jiang T.; Kuhen K.L.; Wolff K.; Yin H.; Bieza K.; Caldwell J.; Bursulaya B.; Tuntland T.; Zhang K.; Karanewsky D.; He Y.; Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2. Bioorg Med Chem Lett 2006,16(8),2109-2112","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.bmcl.2006.01.063","volume":"16","author":"Tripathy R.","year":"2006","unstructured":"Tripathy R.; Reiboldt A.; Messina P.A.; Iqbal M.; Singh J.; Bacon E.R.; Angeles T.S.; Yang S.X.; Albom M.S.; Robinson C.; Chang H.; Ruggeri B.A.; Mallamo J.P.; Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis. Bioorg Med Chem Lett 2006,16(8),2158-2162","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/bbrc.2000.3477","volume":"276","author":"Cane A.","year":"2000","unstructured":"Cane A.; Tournaire M-C.; Barritault D.; Crumeyrolle-Arias M.; The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem Biophys Res Commun 2000,276(1),379-384","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jinorgbio.2007.12.033","volume":"102","author":"da Silveira V.C.","year":"2008","unstructured":"da Silveira V.C.; Luz J.S.; Oliveira C.C.; Graziani I.; Ciriolo M.R.; da Costa Ferreira A.M.; Double-strand DNA cleavage induced by oxindole-Schiff base copper(II) complexes with potential antitumor activity. J Inorg Biochem 2008,102(5-6),1090-1103","journal-title":"J Inorg Biochem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jinorgbio.2006.09.004","volume":"101","author":"Rodr\u00edguez-Arg\u00fcelles M.C.","year":"2007","unstructured":"Rodr\u00edguez-Arg\u00fcelles M.C.; Mosquera-V\u00e1zquez S.; Tour\u00f3n-Touceda P.; Sanmart\u00edn-Matalobos J.; Garc\u00eda-Deibe A.M.; Belicchi-Ferrari M.; Pelosi G.; Pelizzi C.; Zani F.; Complexes of 2-thiophenecarbonyl and isonicotinoyl hydrazones of 3-(N-methyl)isatin. A study of their antimicrobial activity. J Inorg Biochem 2007,101(1),138-147","journal-title":"J Inorg Biochem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0968-0896(02)00439-X","volume":"11","author":"Raj A.A.","year":"2003","unstructured":"Raj A.A.; Raghunathan R.; SrideviKumari, M.R.; Raman, N. Synthesis, antimicrobial and antifungal activity of a new class of spiro pyrrolidines. Bioorg Med Chem 2003,11(3),407-419","journal-title":"Bioorg Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.bmcl.2006.12.108","volume":"17","author":"Maskell L.","year":"2007","unstructured":"Maskell L.; Blanche E.A.; Colucci M.A.; Whatmore J.L.; Moody C.J.; Synthesis and evaluation of prodrugs for anti-angiogenic pyrrolylmethylidenyl oxindoles. Bioorg Med Chem Lett 2007,17(6),1575-1578","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=35","first-page":"49","volume":"54","author":"Verma M.","year":"2004","unstructured":"Verma M.; Pandeya S.N.; Singh K.N.; Stables J.P.; Anticonvulsant activity of Schiff bases of isatin derivatives. Acta Pharm 2004,54(1),49-56","journal-title":"Acta Pharm"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neuint.2005.02.011","volume":"47","author":"Igosheva N.","year":"2005","unstructured":"Igosheva N.; Lorz C.; O\u2019Conner E.; Glover V.; Mehmet H.; Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells. Neurochem Int 2005,47(3),216-224","journal-title":"Neurochem Int"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1021\/jm701080t","volume":"51","author":"Fensome A.","year":"2008","unstructured":"Fensome A.; Adams W.R.; Adams A.L.; Berrodin T.J.; Cohen J.; Huselton C.; Illenberger A.; Kern J.C.; Hudak V.A.; Marella M.A.; Melenski E.G.; McComas C.C.; Mugford C.A.; Slayden O.D.; Yudt M.; Zhang Z.; Zhang P.; Zhu Y.; Winneker R.C.; Wrobel J.E.; Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348). J Med Chem 2008,51(6),1861-1873","journal-title":"J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ejmech.2011.01.037","volume":"46","author":"Kumari G.","year":"2011","unstructured":"Kumari G.; Nutan M.; Modi M.; Gupta S.K.; Singh R.K.; Rhodium(II) acetate-catalyzed stereoselective synthesis, SAR and anti-HIV activity of novel oxindoles bearing cyclopropane ring. Eur J Med Chem 2011,46(4),1181-1188","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.1021\/ja051147z","volume":"127","author":"Ding K.","year":"2005","unstructured":"Ding K.; Lu Y.; Nikolovska-Coleska Z.; Qiu S.; Ding Y.; Gao W.; Stuckey J.; Krajewski K.; Roller P.P.; Tomita Y.; Parrish D.A.; Deschamps J.R.; Wang S.; Structure-based design of potent non-peptide MDM2 inhibitors. J Am Chem Soc 2005,127(29),10130-10131","journal-title":"J Am Chem Soc"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"16077","DOI":"10.1021\/ja045089d","volume":"126","author":"Lo M.M.","year":"2004","unstructured":"Lo M.M.; Neumann C.S.; Nagayama S.; Perlstein E.O.; Schreiber S.L.; A library of spirooxindoles based on a stereoselective three-component coupling reaction. J Am Chem Soc 2004,126(49),16077-16086","journal-title":"J Am Chem Soc"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1002\/anie.201002138","volume":"49","author":"Vintonyak V.V.","year":"2010","unstructured":"Vintonyak V.V.; Warburg K.; Kruse H.; Grimme S.; H\u00fcbel K.; Rauh D.; Waldmann H.; Identification of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase B. Angew Chem Int Ed Engl 2010,49(34),5902-5905","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1021\/jm100410f","volume":"53","author":"Yeung B.K.","year":"2010","unstructured":"Yeung B.K.; Zou B.; Rottmann M.; Lakshminarayana S.B.; Ang S.H.; Leong S.Y.; Tan J.; Wong J.; Keller-Maerki S.; Fischli C.; Goh A.; Schmitt E.K.; Krastel P.; Francotte E.; Kuhen K.; Plouffe D.; Henson K.; Wagner T.; Winzeler E.A.; Petersen F.; Brun R.; Dartois V.; Diagana T.T.; Keller T.H.; Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria. J Med Chem 2010,53(14),5155-5164","journal-title":"J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"Rottmann M.","year":"2010","unstructured":"Rottmann M.; McNamara C.; Yeung B.K.; Lee M.C.; Zou B.; Russell B.; Seitz P.; Plouffe D.M.; Dharia N.V.; Tan J.; Cohen S.B.; Spencer K.R.; Gonz\u00e1lez-P\u00e1ez G.E.; Lakshminarayana S.B.; Goh A.; Suwanarusk R.; Jegla T.; Schmitt E.K.; Beck H.P.; Brun R.; Nosten F.; Renia L.; Dartois V.; Keller T.H.; Fidock D.A.; Winzeler E.A.; Diagana T.T.; Spiroindolones, a potent compound class for the treatment of malaria. Science 2010,329(5996),1175-1180","journal-title":"Science"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00280-002-0480-0","volume":"50","author":"Feun L.","year":"2002","unstructured":"Feun L.; Modiano M.; Lee K.; Mao J.; Marini A.; Savaraj N.; Plezia P.; Almassian B.; Colacino E.; Fischer J.; MacDonald S.; Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule. Cancer Chemother Pharmacol 2002,50(3),223-229","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1023\/A:1022543718598","volume":"16","author":"Kovala-Demertzi D.","year":"2003","unstructured":"Kovala-Demertzi D.; Demertzis M.A.; Filiou E.; Pantazaki A.A.; Yadav P.N.; Miller J.R.; Zheng Y.; Kyriakidis D.A.; Platinum(II) and palladium(II) complexes with 2-acetyl pyridine 4N-ethyl thiosemicarbazone able to overcome the cis-platin resistance. Structure, antibacterial activity and DNA strand breakage. Biometals 2003,16(3),411-418","journal-title":"Biometals"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0162-0134(03)00156-9","volume":"96","author":"Kasuga N.C.","year":"2003","unstructured":"Kasuga N.C.; Sekino K.; Ishikawa M.; Honda A.; Yokoyama M.; Nakano S.; Shimada N.; Koumo C.; Nomiya K.; Synthesis, structural characterization and antimicrobial activities of 12 zinc(II) complexes with four thiosemicarbazone and two semicarbazone ligands. J Inorg Biochem 2003,96(2-3),298-310","journal-title":"J Inorg Biochem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1021\/tx800182k","volume":"21","author":"Opletalov\u00e1 V.","year":"2008","unstructured":"Opletalov\u00e1 V.; Kalinowski D.S.; Vejsov\u00e1 M.; Kunes J.; Pour M.; Jamp\u00edlek J.; Buchta V.; Richardson D.R.; Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity. Chem Res Toxicol 2008,21(9),1878-1889","journal-title":"Chem Res Toxicol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0166-3542(94)90077-9","volume":"24","author":"Teitz Y.","year":"1994","unstructured":"Teitz Y.; Ronen D.; Vansover A.; Stematsky T.; Riggs J.L.; Inhibition of human immunodeficiency virus by N-methylisatin-beta 4\u2032:4\u2032-diethylthiosemicarbazone and N-allylisatin-beta-4\u2032:4\u2032-diallythiosemicarbazone. Antiviral Res 1994,24(4),305-314","journal-title":"Antiviral Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1016\/S0960-894X(02)00703-5","volume":"12","author":"Bharti N.","year":"2002","unstructured":"Bharti N.; Husain K.; Gonzalez Garza M.T.; Cruz-Vega D.E.; Castro-Garza J.; Mata-Cardenas B.D.; Naqvi F.; Azam A.; Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives. Bioorg Med Chem Lett 2002,12(23),3475-3478","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1021\/jm060727j","volume":"49","author":"Das J.","year":"2006","unstructured":"Das J.; Chen P.; Norris D.; Padmanabha R.; Lin J.; Moquin R.V.; Shen Z.; Cook L.S.; Doweyko A.M.; Pitt S.; Pang S.; Shen D.R.; Fang Q.; de Fex H.F.; McIntyre K.W.; Shuster D.J.; Gillooly K.M.; Behnia K.; Schieven G.L.; Wityak J.; Barrish J.C.; 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. J Med Chem 2006,49(23),6819-6832","journal-title":"J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1590\/S0100-40422003000300014","volume":"26","author":"de Souza M.V.","year":"2003","unstructured":"de Souza M.V.; de Almeida M.V.; Drogas anti-VIH: passado, presente e perspectivas futuras. Quim Nova 2003,26,366-372","journal-title":"Quim Nova"},{"key":"ref=52","first-page":"165","volume":"11","author":"Pasqualotto A.C.","year":"2010","unstructured":"Pasqualotto A.C.; Thiele K.O.; Goldani L.Z.; Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole. Curr Opin Investig Drugs 2010,11(2),165-174","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","volume":"40","author":"Fox L.M.","year":"2005","unstructured":"Fox L.M.; Saravolatz L.D.; Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005,40(8),1173-1180","journal-title":"Clin Infect Dis"},{"key":"ref=54","first-page":"175","volume":"14","author":"Knadler M.P.","year":"1986","unstructured":"Knadler M.P.; Bergstrom R.F.; Callaghan J.T.; Rubin A.; Nizatidine, an H2-blocker. Its metabolism and disposition in man. Drug Metab Dispos 1986,14(2),175-182","journal-title":"Drug Metab Dispos"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0048-3575(03)00065-8","volume":"76","author":"Nauen R.","year":"2003","unstructured":"Nauen R.; Ebbinghaus-Kintscher U.; Salgado V.L.; Kaussmann M.; Thiamethoxam is a neonicotinoid precursor converted to clothianidin in insects and plants. Pestic Biochem Physiol 2003,76,55-69","journal-title":"Pestic Biochem Physiol"},{"key":"ref=56","first-page":"415","volume":"44","author":"el-Khawass S.M.","year":"1989","unstructured":"el-Khawass S.M.; Khalil M.A.; Chaaban I.; Synthesis of some thiazoline and thiazolidinone derivatives of 1,4-benzoquinone as potential antimicrobial agents. Farmaco 1989,44(4),415-421","journal-title":"Farmaco"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1016\/S0960-894X(03)00673-5","volume":"13","author":"Babaoglu K.","year":"2003","unstructured":"Babaoglu K.; Page M.A.; Jones V.C.; McNeil M.R.; Dong C.; Naismith J.H.; Lee R.E.; Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis. Bioorg Med Chem Lett 2003,13(19),3227-3230","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=58","first-page":"1399","volume":"130","author":"\u00c7apan G.","year":"1999","unstructured":"\u00c7apan G.; Ulusoy N.; Ergen\u00e7 N.; Kiraz M.; New 6-Phenylimidazo[2,1-b]thiazole derivatives: Synthesis and antifungal activity. Monatshefte F\u00fcr Chemie. Chem Mon 1999,130,1399-1407","journal-title":"Chem Mon"},{"key":"ref=59","first-page":"1167","volume":"48","author":"Alves A.J.","year":"1993","unstructured":"Alves A.J.; Leite A.C.; De Santana D.P.; Beltrao T.M.; Coelho M.R.; Gayral P.; Synthesis of some 4-oxo-delta 2-thiazolin-2-ylhydrazones as potential antiprotozoal agents. Farmaco 1993,48(8),1167-1171","journal-title":"Farmaco"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1016\/j.bmc.2005.07.063","volume":"13","author":"Rawal R.K.","year":"2005","unstructured":"Rawal R.K.; Prabhakar Y.S.; Katti S.B.; De Clercq E.; 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors. Bioorg Med Chem 2005,13(24),6771-6776","journal-title":"Bioorg Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/S0960-894X(01)00476-0","volume":"11","author":"Vigorita M.G.","year":"2001","unstructured":"Vigorita M.G.; Ottan\u00e0 R.; Monforte F.; Maccari R.; Trovato A.; Monforte M.T.; Taviano M.F.; Synthesis and antiinflammatory, analgesic activity of 3,3\u2032-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. Bioorg Med Chem Lett 2001,11(21),2791-2794","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm049208b","volume":"48","author":"Gududuru V.","year":"2005","unstructured":"Gududuru V.; Hurh E.; Dalton J.T.; Miller D.D.; Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer. J Med Chem 2005,48(7),2584-2588","journal-title":"J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1590\/S0100-40422008000200033","volume":"31","author":"Liesen A.P.","year":"2008","unstructured":"Liesen A.P.; De Aquino T.M.; G\u00f3es A.J.; De Lima J.G.; De Faria A.R.; Alves A.J.; M\u00e9todos de obten\u00e7\u00e3o, reatividade e import\u00e2ncia biol\u00f3gica de 4-tiazolidinonas. Quim Nova 2008,31,369-376","journal-title":"Quim Nova"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.bmcl.2005.03.048","volume":"15","author":"Ten\u00f3rio R.P.","year":"2005","unstructured":"Ten\u00f3rio R.P.; Carvalho C.S.; Pessanha C.S.; de Lima J.G.; de Faria A.R.; Alves A.J.; de Melo E.J.; G\u00f3es A.J.; Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity. Bioorg Med Chem Lett 2005,15(10),2575-2578","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bmc.2007.09.025","volume":"16","author":"de Aquino T.M.","year":"2008","unstructured":"de Aquino T.M.; Liesen A.P.; da Silva R.E.; Lima V.T.; Carvalho C.S.; de Faria A.R.; de Ara\u00fajo J.M.; de Lima J.G.; Alves A.J.; de Melo E.J.; G\u00f3es A.J.; Synthesis, anti-Toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3-thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids. Bioorg Med Chem 2008,16(1),446-456","journal-title":"Bioorg Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1016\/j.ejmech.2010.05.017","volume":"45","author":"Liesen A.P.","year":"2010","unstructured":"Liesen A.P.; de Aquino T.M.; Carvalho C.S.; Lima V.T.; de Ara\u00fajo J.M.; de Lima J.G.; de Faria A.R.; de Melo E.J.; Alves A.J.; Alves E.W.; Alves A.Q.; G\u00f3es A.J.; Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. Eur J Med Chem 2010,45(9),3685-3691","journal-title":"Eur J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.bmc.2006.01.034","volume":"14","author":"Leite A.C.","year":"2006","unstructured":"Leite A.C.; de Lima R.S.; Moreira D.R.; Cardoso M.V.; Gouveia de Brito A.C.; Farias Dos Santos L.M.; Hernandes M.Z.; Kiperstok A.C.; de Lima R.S.; Soares M.B.; Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi. Bioorg Med Chem 2006,14(11),3749-3757","journal-title":"Bioorg Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/cmdc.200700022","volume":"2","author":"Leite A.C.","year":"2007","unstructured":"Leite A.C.; Moreira D.R.; Cardoso M.V.; Hernandes M.Z.; Alves Pereira V.R.; Silva R.O.; Kiperstok A.C.; Lima, Mda.S.; Soares, M.B. Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi. ChemMedChem 2007,2(9),1339-1345","journal-title":"ChemMedChem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1016\/j.bmc.2010.09.056","volume":"18","author":"Hernandes M.Z.","year":"2010","unstructured":"Hernandes M.Z.; Rabello M.M.; Leite A.C.; Cardoso M.V.; Moreira D.R.; Brondani D.J.; Simone C.A.; Reis L.C.; Souza M.A.; Pereira V.R.; Ferreira R.S.; McKerrow J.H.; Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents. Bioorg Med Chem 2010,18(22),7826-7835","journal-title":"Bioorg Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"10918","DOI":"10.1021\/jm301518v","volume":"55","author":"Moreira D.R.","year":"2012","unstructured":"Moreira D.R.; Costa S.P.; Hernandes M.Z.; Rabello M.M.; de Oliveira Filho G.B.; de Melo C.M.; da Rocha L.F.; de Simone C.A.; Ferreira R.S.; Fradico J.R.; Meira C.S.; Guimar\u00e3es E.T.; Srivastava R.M.; Pereira V.R.; Soares M.B.; Leite A.C.; Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice. J Med Chem 2012,55(24),10918-10936","journal-title":"J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cmdc.201300354","volume":"9","author":"Moreira D.R.","year":"2014","unstructured":"Moreira D.R.; Leite A.C.; Cardoso M.V.; Srivastava R.M.; Hernandes M.Z.; Rabello M.M.; da Cruz L.F.; Ferreira R.S.; de Simone C.A.; Meira C.S.; Guimaraes E.T.; da Silva A.C.; dos Santos T.A.; Pereira V.R.; Soares M.B.; Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity. ChemMedChem 2014,9(1),177-188","journal-title":"ChemMedChem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1016\/j.bmc.2015.10.048","volume":"23","author":"de Oliveira Filho G.B.","year":"2015","unstructured":"de Oliveira Filho G.B.; de Oliveira Cardoso M.V.; Esp\u00edndola J.W.; Ferreira L.F.; de Simone C.A.; Ferreira R.S.; Coelho P.L.; Meira C.S.; Magalhaes Moreira D.R.; Soares M.B.; Lima Leite.; A.C. Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi. Bioorg Med Chem 2015,23(23),7478-7486","journal-title":"Bioorg Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.neuint.2007.07.006","volume":"52","author":"Chandra J.N.","year":"2008","unstructured":"Chandra J.N.; Malviya M.; Sadashiva C.T.; Subhash M.N.; Rangappa K.S.; Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer\u2019s dementia models. Neurochem Int 2008,52(3),376-383","journal-title":"Neurochem Int"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.bmc.2015.02.002","volume":"23","author":"Crasc\u00ec L.","year":"2015","unstructured":"Crasc\u00ec L.; Vicini P.; Incerti M.; Cardile V.; Avondo S.; Panico A.; 2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction. Bioorg Med Chem 2015,23(7),1551-1556","journal-title":"Bioorg Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00706-015-1549-x","volume":"147","author":"Ashour H.M.","year":"2016","unstructured":"Ashour H.M.; El-Ashmawy I.M.; Bayad A.E.; Synthesis and pharmacological evaluation of new pyrazolyl benzenesulfonamides linked to polysubstituted pyrazoles and thiazolidinones as anti-inflammatory and analgesic agents. Monatsh Chem 2016,147,605-618","journal-title":"Monatsh Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1016\/j.bmc.2005.04.058","volume":"13","author":"Ottan\u00e0 R.","year":"2005","unstructured":"Ottan\u00e0 R.; Maccari R.; Barreca M.L.; Bruno G.; Rotondo A.; Rossi A.; Chiricosta G.; Di Paola R.; Sautebin L.; Cuzzocrea S.; Vigorita M.G.; 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents. Bioorg Med Chem 2005,13(13),4243-4252","journal-title":"Bioorg Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bmc.2015.12.008","volume":"24","author":"Cihan-\u00dcst\u00fcnda\u011f G.","year":"2016","unstructured":"Cihan-\u00dcst\u00fcnda\u011f G.; G\u00fcrsoy E.; Naesens L.; Ulusoy-G\u00fczeldemirci N.; \u00c7apan G.; Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones. Bioorg Med Chem 2016,24(2),240-246","journal-title":"Bioorg Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1016\/j.bmcl.2005.05.093","volume":"15","author":"Ottan\u00e0 R.","year":"2005","unstructured":"Ottan\u00e0 R.; Carotti S.; Maccari R.; Landini I.; Chiricosta G.; Caciagli B.; Vigorita M.G.; Mini E.; In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. Bioorg Med Chem Lett 2005,15(17),3930-3933","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ejmech.2009.10.044","volume":"45","author":"Kamel M.M.","year":"2010","unstructured":"Kamel M.M.; Ali H.I.; Anwar M.M.; Mohamed N.A.; Soliman A.M.; Synthesis, antitumor activity and molecular docking study of novel sulfonamide-Schiff\u2019s bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. Eur J Med Chem 2010,45(2),572-580","journal-title":"Eur J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.1016\/j.ejmech.2010.08.008","volume":"45","author":"Havrylyuk D.","year":"2010","unstructured":"Havrylyuk D.; Mosula L.; Zimenkovsky B.; Vasylenko O.; Gzella A.; Lesyk R.; Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur J Med Chem 2010,45(11),5012-5021","journal-title":"Eur J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejmech.2016.03.089","volume":"117","author":"Senkiv J.","year":"2016","unstructured":"Senkiv J.; Finiuk N.; Kaminskyy D.; Havrylyuk D.; Wojtyra M.; Kril I.; Gzella A.; Stoika R.; Lesyk R.; 5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells. Eur J Med Chem 2016,117,33-46","journal-title":"Eur J Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00894-006-0138-7","volume":"13","author":"Rawal R.K.","year":"2007","unstructured":"Rawal R.K.; Kumar A.; Siddiqi M.I.; Katti S.B.; Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors. J Mol Model 2007,13(1),155-161","journal-title":"J Mol Model"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejmech.2016.04.012","volume":"117","author":"Secci D.","year":"2016","unstructured":"Secci D.; Carradori S.; Bizzarri B.; Chimenti P.; De Monte C.; Mollica A.; Rivanera D.; Zicari A.; Mari E.; Zengin G.; Aktumsek A.; Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties. Eur J Med Chem 2016,117,144-156","journal-title":"Eur J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1016\/j.ejmech.2009.05.015","volume":"44","author":"Aridoss G.","year":"2009","unstructured":"Aridoss G.; Amirthaganesan S.; Kim M.S.; Kim J.T.; Jeong Y.T.; Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones. Eur J Med Chem 2009,44(10),4199-4210","journal-title":"Eur J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5539\/ijc.v3n2p117","volume":"3","author":"Patel D.","year":"2011","unstructured":"Patel D.; Patel N.; Kumari P.; Patel N.; Synthesis and characterization of some new azetidin-2-ones containing coumarin moiety and their antimicrobial study. Int J Chem 2011,3,117-123","journal-title":"Int J Chem"},{"key":"ref=86","unstructured":"HO, WHO | Chagas disease (American trypanosomiasis), World Heal. Organ. (2015). Available at:[Accessed November 18, 2015]."},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1073\/pnas.0307312101","volume":"101","author":"Aufderheide A.C.","year":"2004","unstructured":"Aufderheide A.C.; Salo W.; Madden M.; Streitz J.; Buikstra J.; Guhl F.; Arriaza B.; Renier C.; Wittmers L.E.; Fornaciari G.; Allison M.A.; 9,000-year record of Chagas\u2019 disease. Proc Natl Acad Sci USA 2004,101(7),2034-2039","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000300","volume":"2","author":"Hotez P.J.","year":"2008","unstructured":"Hotez P.J.; Bottazzi M.E.; Franco-Paredes C.; Ault S.K.; Periago M.R.; The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2008,2(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","volume":"13","author":"Lee B.Y.","year":"2013","unstructured":"Lee B.Y.; Bacon K.M.; Bottazzi M.E.; Hotez P.J.; Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis 2013,13(4),342-348","journal-title":"Lancet Infect Dis"},{"key":"ref=90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040332","volume":"4","author":"Tarleton R.L.","year":"2007","unstructured":"Tarleton R.L.; Reithinger R.; Urbina J.A.; Kitron U.; G\u00fcrtler R.E.; The challenges of Chagas Disease-- grim outlook or glimmer of hope. PLoS Med 2007,4(12)","journal-title":"PLoS Med"},{"key":"ref=91","year":"2016","unstructured":"WHO. 2016, WHO | What is human african trypanosomiasis2016"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd1824","volume":"4","author":"Pink R.","year":"2005","unstructured":"Pink R.; Hudson A.; Mouri\u00e8s M-A.; Bendig M.; Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov 2005,4(9),727-740","journal-title":"Nat Rev Drug Discov"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/S0140-6736(89)92340-4","volume":"1","author":"Pepin J.","year":"1989","unstructured":"Pepin J.; Milord F.; Guern C.; Mpia B.; Ethier L.; Mansinsa D.; Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness. Lancet 1989,1(8649),1246-1250","journal-title":"Lancet"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejmech.2013.11.017","volume":"72","author":"Tripathi A.C.","year":"2014","unstructured":"Tripathi A.C.; Gupta S.J.; Fatima G.N.; Sonar P.K.; Verma A.; Saraf S.K.; 4-Thiazolidinones: the advances continue\u2026. Eur J Med Chem 2014,72,52-77","journal-title":"Eur J Med Chem"},{"key":"ref=95","year":"2016","unstructured":"WHO. 2016, WHO | Leishmaniasis2016"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"Desjeux P.","year":"2004","unstructured":"Desjeux P.; Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004,27(5),305-318","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/cr500365f","volume":"114","author":"Nagle A.S.","year":"2014","unstructured":"Nagle A.S.; Khare S.; Kumar A.B.; Supek F.; Buchynskyy A.; Mathison C.J.; Chennamaneni N.K.; Pendem N.; Buckner F.S.; Gelb M.H.; Molteni V.; Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem Rev 2014,114(22),11305-11347","journal-title":"Chem Rev"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ijbiomac.2012.01.010","volume":"50","author":"Ansari M.Y.","year":"2012","unstructured":"Ansari M.Y.; Dikhit M.R.; Sahoo G.C.; Das P.; Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP. Int J Biol Macromol 2012,50(3),637-649","journal-title":"Int J Biol Macromol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijbiomac.2015.11.051","volume":"83","author":"Ansari M.Y.","year":"2016","unstructured":"Ansari M.Y.; Equbal A.; Dikhit M.R.; Mansuri R.; Rana S.; Ali V.; Sahoo G.C.; Das P.; Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors. Int J Biol Macromol 2016,83,78-96","journal-title":"Int J Biol Macromol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.genrep.2017.07.003","volume":"8","author":"Ansari M.Y.","year":"2017","unstructured":"Ansari M.Y.; Ahsan M.J.; Yasmin S.; Sahoo G.C.; Saini V.; Das P.; In silico identification of novel antagonists and binding insights by structural and functional analyses of guanylate kinase of Leishmania donovani and interaction with inhibitors. Gene Rep 2017,8,134-143","journal-title":"Gene Rep"},{"key":"ref=101","first-page":"119","volume":"5","author":"Ahsan M.J.","year":"2016","unstructured":"Ahsan M.J.; Ansari M.Y.; Kumar P.; Soni M.; Yasmin S.; Jadav S.S.; In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues, Beni-Suef Univ. J Basic Appl Sci 2016,5,119-125","journal-title":"J Basic Appl Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2174\/156802611795429194","volume":"11","author":"Burrows J.N.","year":"2011","unstructured":"Burrows J.N.; Chibale K.; Wells T.N.; The state of the art in anti-malarial drug discovery and development. Curr Top Med Chem 2011,11(10),1226-1254","journal-title":"Curr Top Med Chem"},{"key":"ref=103","year":"2016","unstructured":"WHO. 2016, WHO | Malaria,2016"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"Gamo F-J.","year":"2010","unstructured":"Gamo F-J.; Sanz L.M.; Vidal J.; de Cozar C.; Alvarez E.; Lavandera J-L.; Vanderwall D.E.; Green D.V.; Kumar V.; Hasan S.; Brown J.R.; Peishoff C.E.; Cardon L.R.; Garcia-Bustos J.F.; Thousands of chemical starting points for antimalarial lead identification. Nature 2010,465(7296),305-310","journal-title":"Nature"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nm0307-295","volume":"13","author":"Dorman S.E.","year":"2007","unstructured":"Dorman S.E.; Chaisson R.E.; From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nat Med 2007,13(3),295-298","journal-title":"Nat Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0966-842X(93)90015-J","volume":"1","author":"Kaufmann S.H.","year":"1993","unstructured":"Kaufmann S.H.; van Embden J.D.; Tuberculosis: a neglected disease strikes back. Trends Microbiol 1993,1(1),2-5","journal-title":"Trends Microbiol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrd4001","volume":"12","author":"Zumla A.","year":"2013","unstructured":"Zumla A.; Nahid P.; Cole S.T.; Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 2013,12(5),388-404","journal-title":"Nat Rev Drug Discov"},{"key":"ref=108","first-page":"1689","volume":"2015","author":"Lewandowski C.M.","year":"2015","unstructured":"Lewandowski C.M.; Co-investigator N.; Lewandowski C.M.; WHO Glocal tuberculosis report 2015, WHO - Glob. Tuberc Rep 2015,2015(1),1689-1699","journal-title":"Tuberc Rep"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1038\/ncomms12581","volume":"7","author":"Abrahams K.A.","year":"2016","unstructured":"Abrahams K.A.; Chung C.W.; Ghidelli-Disse S.; Rullas J.; Rebollo-L\u00f3pez M.J.; Gurcha S.S.; Cox J.A.; Mendoza A.; Jim\u00e9nez-Navarro E.; Mart\u00ednez-Mart\u00ednez M.S.; Neu M.; Shillings A.; Homes P.; Argyrou A.; Casanueva R.; Loman N.J.; Moynihan P.J.; Leli\u00e8vre J.; Selenski C.; Axtman M.; Kremer L.; Bantscheff M.; Angulo-Barturen I.; Izquierdo M.C.; Cammack N.C.; Drewes G.; Ballell L.; Barros D.; Besra G.S.; Bates R.H.; Identification of KasA as the cellular target of an anti-tubercular scaffold. Nat Commun 2016,7,12581","journal-title":"Nat Commun"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cll.2009.10.007","volume":"30","author":"Ross T.M.","year":"2010","unstructured":"Ross T.M.; Dengue virus. Clin Lab Med 2010,30(1),149-160","journal-title":"Clin Lab Med"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1473-3099(07)70107-X","volume":"7","author":"Pialoux G.","year":"2007","unstructured":"Pialoux G.; Ga\u00fcz\u00e8re B-A.; Jaur\u00e9guiberry S.; Strobel M.; Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007,7(5),319-327","journal-title":"Lancet Infect Dis"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3201\/eid1509.090442","volume":"15","author":"Hayes E.B.","year":"2009","unstructured":"Hayes E.B.; Zika virus outside Africa. Emerg Infect Dis 2009,15(9),1347-1350","journal-title":"Emerg Infect Dis"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"Bhatt S.","year":"2013","unstructured":"Bhatt S.; Gething P.W.; Brady O.J.; Messina J.P.; Farlow A.W.; Moyes C.L.; Drake J.M.; Brownstein J.S.; Hoen A.G.; Sankoh O.; Myers M.F.; George D.B.; Jaenisch T.; Wint G.R.; Simmons C.P.; Scott T.W.; Farrar J.J.; Hay S.I.; The global distribution and burden of dengue. Nature 2013,496(7446),504-507","journal-title":"Nature"},{"key":"ref=114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001760","volume":"6","author":"Brady O.J.","year":"2012","unstructured":"Brady O.J.; Gething P.W.; Bhatt S.; Messina J.P.; Brownstein J.S.; Hoen A.G.; Moyes C.L.; Farlow A.W.; Scott T.W.; Hay S.I.; Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 2012,6(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/cmdc.200900525","volume":"5","author":"Pessoa C.","year":"2010","unstructured":"Pessoa C.; Ferreira P.M.; Lotufo L.V.; de Moraes M.O.; Cavalcanti S.M.; Co\u00ealho L.C.; Hernandes M.Z.; Leite A.C.; De Simone C.A.; Costa V.M.; Souza V.M.; Discovery of phthalimides as immunomodulatory and antitumor drug prototypes. ChemMedChem 2010,5(4),523-528","journal-title":"ChemMedChem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.bmcl.2012.02.045","volume":"22","author":"Long T.E.","year":"2012","unstructured":"Long T.E.; Lu X.; Galizzi M.; Docampo R.; Gut J.; Rosenthal P.J.; Phosphonium lipocations as antiparasitic agents. Bioorg Med Chem Lett 2012,22(8),2976-2979","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1016\/j.bmcl.2014.09.061","volume":"24","author":"Gonz\u00e1lez M.A.","year":"2014","unstructured":"Gonz\u00e1lez M.A.; Clark J.; Connelly M.; Rivas F.; Antimalarial activity of abietane ferruginol analogues possessing a phthalimide group. Bioorg Med Chem Lett 2014,24(22),5234-5237","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.bmc.2015.02.029","volume":"23","author":"Singh A.K.","year":"2015","unstructured":"Singh A.K.; Rajendran V.; Pant A.; Ghosh P.C.; Singh N.; Latha N.; Garg S.; Pandey K.C.; Singh B.K.; Rathi B.; Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite. Bioorg Med Chem 2015,23(8),1817-1827","journal-title":"Bioorg Med Chem"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1016\/j.bmc.2009.04.042","volume":"17","author":"Santos J.L.","year":"2009","unstructured":"Santos J.L.; Yamasaki P.R.; Chin C.M.; Takashi C.H.; Pavan F.R.; Leite C.Q.; Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives. Bioorg Med Chem 2009,17(11),3795-3799","journal-title":"Bioorg Med Chem"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2016.01.010","volume":"111","author":"Gomes P.A.","year":"2016","unstructured":"Gomes P.A.; Oliveira A.R.; Cardoso M.V.; Santiago, Ede.F.; Barbosa, Mde.O.; de Siqueira, L.R.; Moreira, D.R.; Bastos, T.M.; Brayner, F.A.; Soares, M.B.; Mendes, A.P.; de Castro, M.C.; Pereira, V.R.; Leite, A.C. Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi. Eur J Med Chem 2016,111,46-57","journal-title":"Eur J Med Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1128\/AAC.01900-13","volume":"58","year":"2014","unstructured":"Santiago, Ede.F.; de Oliveira, S.A.; de Oliveira Filho, G.B.; Moreira, D.R.; Gomes, P.A.; da Silva, A.L.; de Barros, A.F.; da Silva, A.C.; Dos Santos, T.A.; Pereira, V.R.; Gon\u00e7alves, G.G.; Brayner, F.A.; Alves, L.C.; Wanderley, A.G.; Leite, A.C. Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles. Antimicrob Agents Chemother 2014,58(1),352-363","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=122","first-page":"853","volume":"52","author":"Rad R.","year":"2007","unstructured":"Rad R.; Mracec M.; Mracec M.; Oprea T.; The privileged structures hypothesis for G proteincoupled receptors - some preliminar results. Rev Roum Chim 2007,52,853-858","journal-title":"Rev Roum Chim"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2174\/138955709788452649","volume":"9","author":"de S\u00e1 Alves F.R.","year":"2009","unstructured":"de S\u00e1 Alves F.R.; Barreiro E.J.; Fraga C.A.; From nature to drug discovery: the indole scaffold as a \u2018privileged structure\u2019. Mini Rev Med Chem 2009,9(7),782-793","journal-title":"Mini Rev Med Chem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccr.2008.04.012","volume":"253","author":"Shimazaki Y.","year":"2009","unstructured":"Shimazaki Y.; Yajima T.; Takani M.; Yamauchi O.; Metal complexes involving indole rings: Structures and effects of metal-indole interactions. Coord Chem Rev 2009,253,479-492","journal-title":"Coord Chem Rev"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/S0040-4020(01)96609-8","volume":"41","author":"Bergman J.","year":"1985","unstructured":"Bergman J.; Lindstr\u00f6m J-O.; Tilstam U.; The structure and properties of some indolic constituents in Couroupita guianensis aubl. Tetrahedron 1985,41,2879-2881","journal-title":"Tetrahedron"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1016\/S0960-894X(03)00756-X","volume":"13","author":"Chiyanzu I.","year":"2003","unstructured":"Chiyanzu I.; Hansell E.; Gut J.; Rosenthal P.J.; McKerrow J.H.; Chibale K.; Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg Med Chem Lett 2003,13(20),3527-3530","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/cber.186900201293","volume":"2","author":"Kekul\u00e9 A.","year":"1869","unstructured":"Kekul\u00e9 A.; Ueber die Constitution des Isatins, der Isatins\u00e4ure und des Indols. Ber Dtsch Chem Ges 1869,2,748-749","journal-title":"Ber Dtsch Chem Ges"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1021\/cr300135y","volume":"112","author":"Singh G.S.","year":"2012","unstructured":"Singh G.S.; Desta Z.Y.; Isatins as privileged molecules in design and synthesis of spiro-fused cyclic frameworks. Chem Rev 2012,112(11),6104-6155","journal-title":"Chem Rev"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ejmech.2013.01.032","volume":"62","author":"Raj R.","year":"2013","unstructured":"Raj R.; Singh P.; Singh P.; Gut J.; Rosenthal P.J.; Kumar V.; Azide-alkyne cycloaddition en route to 1H-1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation. Eur J Med Chem 2013,62,590-596","journal-title":"Eur J Med Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bmcl.2013.12.109","volume":"24","author":"Raj R.","year":"2014","unstructured":"Raj R.; Gut J.; Rosenthal P.J.; Kumar V.; 1H-1,2,3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: synthesis and antimalarial evaluation. Bioorg Med Chem Lett 2014,24(3),756-759","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/cbdd.12273","volume":"83","author":"Raj R.","year":"2014","unstructured":"Raj R.; Biot C.; Carr\u00e8re-Kremer S.; Kremer L.; Gu\u00e9rardel Y.; Gut J.; Rosenthal P.J.; Forge D.; Kumar V.; 7-chloroquinoline-isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation. Chem Biol Drug Des 2014,83(5),622-629","journal-title":"Chem Biol Drug Des"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.drudis.2015.02.004","volume":"20","author":"Martinez-Mayorga K.","year":"2015","unstructured":"Martinez-Mayorga K.; Byler K.G.; Ramirez-Hernandez A.I.; Terrazas-Alvares D.E.; Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits. Drug Discov Today 2015,20(7),890-898","journal-title":"Drug Discov Today"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3109\/14756366.2013.836641","volume":"29","author":"Pervez H.","year":"2014","unstructured":"Pervez H.; Manzoor N.; Yaqub M.; Khan K.M.; 5-Nitroisatin-derived thiosemicarbazones: potential antileishmanial agents. J Enzyme Inhib Med Chem 2014,29(5),628-632","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.fitote.2008.10.009","volume":"80","author":"Mishra B.B.","year":"2009","unstructured":"Mishra B.B.; Kale R.R.; Singh R.K.; Tiwari V.K.; Alkaloids: future prospective to combat leishmaniasis. Fitoterapia 2009,80(2),81-90","journal-title":"Fitoterapia"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1039\/b100455g","volume":"18","author":"Chan-Bacab M.J.","year":"2001","unstructured":"Chan-Bacab M.J.; Pe\u00f1a-Rodr\u00edguez L.M.; Plant natural products with leishmanicidal activity. Nat Prod Rep 2001,18(6),674-688","journal-title":"Nat Prod Rep"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/138955709787001758","volume":"9","author":"Mishra B.B.","year":"2009","unstructured":"Mishra B.B.; Singh R.K.; Srivastava A.; Tripathi V.J.; Tiwari V.K.; Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents. Mini Rev Med Chem 2009,9(1),107-123","journal-title":"Mini Rev Med Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.2174\/092986710791698521","volume":"17","author":"Lavrado J.","year":"2010","unstructured":"Lavrado J.; Moreira R.; Paulo A.; Indoloquinolines as scaffolds for drug discovery. Curr Med Chem 2010,17(22),2348-2370","journal-title":"Curr Med Chem"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.bmcl.2008.01.015","volume":"18","author":"Lavrado J.","year":"2008","unstructured":"Lavrado J.; Paulo A.; Gut J.; Rosenthal P.J.; Moreira R.; Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: synthesis, antiplasmodial activity, and cytotoxicity. Bioorg Med Chem Lett 2008,18(4),1378-1381","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=139","first-page":"193","volume":"4","author":"Oluwafemi A.J.","year":"2009","unstructured":"Oluwafemi A.J.; Okanla E.O.; Camps P.; Mu\u00f1oz-Torrerob D.; Mackey Z.B.; Chiang P.K.; Seville S.; Wright C.W.; Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African trypanosomiasis. Nat Prod Commun 2009,4(2),193-198","journal-title":"Nat Prod Commun"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1016\/j.bmc.2004.07.003","volume":"12","author":"Aguirre G.","year":"2004","unstructured":"Aguirre G.; Boiani L.; Cerecetto H.; Fern\u00e1ndez M.; Gonz\u00e1lez M.; Denicola A.; Otero L.; Gambino D.; Rigol C.; Olea-Azar C.; Faundez M.; In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones. Bioorg Med Chem 2004,12(18),4885-4893","journal-title":"Bioorg Med Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/jm010459j","volume":"45","author":"Du X.","year":"2002","unstructured":"Du X.; Guo C.; Hansell E.; Doyle P.S.; Caffrey C.R.; Holler T.P.; McKerrow J.H.; Cohen F.E.; Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem 2002,45(13),2695-2707","journal-title":"J Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1021\/jm030549j","volume":"47","author":"Greenbaum D.C.","year":"2004","unstructured":"Greenbaum D.C.; Mackey Z.; Hansell E.; Doyle P.; Gut J.; Caffrey C.R.; Lehrman J.; Rosenthal P.J.; McKerrow J.H.; Chibale K.; Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. J Med Chem 2004,47(12),3212-3219","journal-title":"J Med Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bmcl.2004.10.023","volume":"15","author":"Fujii N.","year":"2005","unstructured":"Fujii N.; Mallari J.P.; Hansell E.J.; Mackey Z.; Doyle P.; Zhou Y.M.; Gut J.; Rosenthal P.J.; McKerrow J.H.; Guy R.K.; Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain. Bioorg Med Chem Lett 2005,15(1),121-123","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1016\/j.bmcl.2006.05.041","volume":"16","author":"Siles R.","year":"2006","unstructured":"Siles R.; Chen S-E.; Zhou M.; Pinney K.G.; Trawick M.L.; Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas\u2019 disease. Bioorg Med Chem Lett 2006,16(16),4405-4409","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1016\/j.bmc.2011.09.037","volume":"19","author":"Caputto M.E.","year":"2011","unstructured":"Caputto M.E.; Fabian L.E.; Ben\u00edtez D.; Merlino A.; R\u00edos N.; Cerecetto H.; Moltrasio G.Y.; Moglioni A.G.; Gonz\u00e1lez M.; Finkielsztein L.M.; Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents. Bioorg Med Chem 2011,19(22),6818-6826","journal-title":"Bioorg Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ejmech.2014.02.001","volume":"75","author":"Magalhaes Moreira D.R.","year":"2014","unstructured":"Magalhaes Moreira D.R.; de Oliveira A.D.; Teixeira de Moraes Gomes P.A.; de Simone C.A.; Villela F.S.; Ferreira R.S.; da Silva A.C.; dos Santos T.A.; Brelaz de Castro M.C.; Pereira V.R.; Leite A.C.; Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death. Eur J Med Chem 2014,75,467-478","journal-title":"Eur J Med Chem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ejmech.2015.06.048","volume":"101","author":"Esp\u00edndola J.W.","year":"2015","unstructured":"Esp\u00edndola J.W.; Cardoso M.V.; Filho G.B.; Oliveira E.; Silva, D.A.; Moreira, D.R.; Bastos, T.M.; Simone, C.A.; Soares, M.B.; Villela, F.S.; Ferreira, R.S.; Castro, M.C.; Pereira, V.R.; Murta, S.M.; Sales Junior, P.A.; Romanha, A.J.; Leite, A.C. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain. Eur J Med Chem 2015,101,818-835","journal-title":"Eur J Med Chem"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jinorgbio.2008.12.004","volume":"103","author":"Vieites M.","year":"2009","unstructured":"Vieites M.; Otero L.; Santos D.; Olea-Azar C.; Norambuena E.; Aguirre G.; Cerecetto H.; Gonz\u00e1lez M.; Kemmerling U.; Morello A.; Diego Maya J.; Gambino D.; Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity. J Inorg Biochem 2009,103(3),411-418","journal-title":"J Inorg Biochem"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejmech.2016.05.003","volume":"120","author":"Rettondin A.R.","year":"2016","unstructured":"Rettondin A.R.; Carneiro Z.A.; Gon\u00e7alves A.C.; Ferreira V.F.; Oliveira C.G.; Lima A.N.; Oliveira R.J.; de Albuquerque S.; Deflon V.M.; Maia P.I.; Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs. Eur J Med Chem 2016,120,217-226","journal-title":"Eur J Med Chem"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12866-014-0236-0","volume":"14","author":"Britta E.A.","year":"2014","unstructured":"Britta E.A.; Scariot D.B.; Falzirolli H.; Ueda-Nakamura T.; Silva C.C.; Filho B.P.; Borsali R.; Nakamura C.V.; Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene. BMC Microbiol 2014,14,236","journal-title":"BMC Microbiol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ejmech.2015.09.009","volume":"103","author":"de Melos J.L.","year":"2015","unstructured":"de Melos J.L.; Torres-Santos E.C.; Fai\u00f5es, Vdos.S.; Del Cistia, Cde.N.; Sant\u2019Anna, C.M.; Rodrigues-Santos, C.E.; Echevarria, A. Novel 3,4-methylenedioxyde-6-X-benzaldehyde-thiosemicarbazones: Synthesis and antileishmanial effects against Leishmania amazonensis. Eur J Med Chem 2015,103,409-417","journal-title":"Eur J Med Chem"},{"key":"ref=152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041440","volume":"7","author":"Britta E.A.","year":"2012","unstructured":"Britta E.A.; Silva A.P.; Ueda-Nakamura T.; Dias-Filho B.P.; Silva C.C.; Sernaglia R.L.; Nakamura C.V.; Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis. PLoS One 2012,7(8)","journal-title":"PLoS One"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1073\/pnas.0307720101","volume":"101","author":"Sijwali P.S.","year":"2004","unstructured":"Sijwali P.S.; Rosenthal P.J.; Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci USA 2004,101(13),4384-4389","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1073\/pnas.0402738101","volume":"101","author":"Sijwali P.S.","year":"2004","unstructured":"Sijwali P.S.; Kato K.; Seydel K.B.; Gut J.; Lehman J.; Klemba M.; Goldberg D.E.; Miller L.H.; Rosenthal P.J.; \n                        Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. Proc Natl Acad Sci USA 2004,101(23),8721-8726","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.ejmech.2007.11.012","volume":"43","author":"de Oliveira R.B.","year":"2008","unstructured":"de Oliveira R.B.; de Souza-Fagundes E.M.; Soares R.P.; Andrade A.A.; Krettli A.U.; Zani C.L.; Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives. Eur J Med Chem 2008,43(9),1983-1988","journal-title":"Eur J Med Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.arabjc.2010.06.042","volume":"4","author":"Duan L.P.","year":"2011","unstructured":"Duan L.P.; Zhang H.B.; Novel thiosemicarbazones derivatives bearing aromatic iodine moiety: Design, synthesis and anti-malarial activity. Arab J Chem 2011,4,231-234","journal-title":"Arab J Chem"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jinorgbio.2010.06.005","volume":"104","author":"Khanye S.D.","year":"2010","unstructured":"Khanye S.D.; Smith G.S.; Lategan C.; Smith P.J.; Gut J.; Rosenthal P.J.; Chibale K.; Synthesis and in vitro evaluation of gold(I) thiosemicarbazone complexes for antimalarial activity. J Inorg Biochem 2010,104(10),1079-1083","journal-title":"J Inorg Biochem"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.bmcl.2007.01.037","volume":"17","author":"Sriram D.","year":"2007","unstructured":"Sriram D.; Yogeeswari P.; Dhakla P.; Senthilkumar P.; Banerjee D.; N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity. Bioorg Med Chem Lett 2007,17(7),1888-1891","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.ejmech.2010.01.028","volume":"45","author":"Pavan F.R.","year":"2010","unstructured":"Pavan F.R.; da S Maia, P.I.; Leite, S.R.; Deflon, V.M.; Batista, A.A.; Sato, D.N.; Franzblau, S.G.; Leite, C.Q. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide\/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur J Med Chem 2010,45(5),1898-1905","journal-title":"Eur J Med Chem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jinorgbio.2013.10.011","volume":"132","author":"Oliveira C.G.","year":"2014","unstructured":"Oliveira C.G.; da S Maia, P.I.; Souza, P.C.; Pavan, F.R.; Leite, C.Q.; Viana, R.B.; Batista, A.A.; Nascimento, O.R.; Deflon, V.M. Manganese(II) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents. J Inorg Biochem 2014,132,21-29","journal-title":"J Inorg Biochem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejmech.2015.04.061","volume":"100","author":"da Silva J.B.","year":"2015","unstructured":"da Silva J.B.; Navarro D.M.; da Silva A.G.; Santos G.K.; Dutra K.A.; Moreira D.R.; Ramos M.N.; Esp\u00edndola J.W.; de Oliveira A.D.; Brondani D.J.; Leite A.C.; Hernandes M.Z.; Pereira V.R.; da Rocha L.F.; de Castro M.C.; de Oliveira B.C.; Lan Q.; Merz K.M.; Jr Thiosemicarbazones as Aedes aegypti larvicidal. Eur J Med Chem 2015,100,162-175","journal-title":"Eur J Med Chem"},{"key":"ref=162","author":"Padmanabhan P.","year":"2016","unstructured":"Padmanabhan P.; Khaleefathullah S.; Kaveri K.; Palani G.; Ramanathan G.; Thennarasu S.; Antiviral activity of Thiosemicarbazones derived from \u03b1-amino acids against Dengue virus. J Med Virol 2016","journal-title":"J Med Virol"},{"key":"ref=163","first-page":"136","volume":"1","author":"Siddiqui N.","year":"2009","unstructured":"Siddiqui N.; Arshad M.F.; Ahsan W.; Alam M.S.; Thiazoles: A valuable insight into the recent advances and biological activities. Int J Pharm Sci Drug Res 2009,1,136-143","journal-title":"Int J Pharm Sci Drug Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1021\/jm201108k","volume":"54","author":"Gonz\u00e1lez Cabrera D.","year":"2011","unstructured":"Gonz\u00e1lez Cabrera D.; Douelle F.; Feng T-S.; Nchinda A.T.; Younis Y.; White K.L.; Wu Q.; Ryan E.; Burrows J.N.; Waterson D.; Witty M.J.; Wittlin S.; Charman S.A.; Chibale K.; Novel orally active antimalarial thiazoles. J Med Chem 2011,54(21),7713-7719","journal-title":"J Med Chem"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2174\/1568011054222319","volume":"5","author":"Wilson W.D.","year":"2005","unstructured":"Wilson W.D.; Nguyen B.; Tanious F.A.; Mathis A.; Hall J.E.; Stephens C.E.; Boykin D.W.; Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity. Curr Med Chem Anticancer Agents 2005,5(4),389-408","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.bmcl.2016.05.039","volume":"26","author":"Scott F.J.","year":"2016","unstructured":"Scott F.J.; Khalaf A.I.; Duffy S.; Avery V.M.; Suckling C.J.; Selective anti-malarial minor groove binders. Bioorg Med Chem Lett 2016,26(14),3326-3329","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1021\/jm500018m","volume":"57","author":"\u00c1lvarez G.","year":"2014","unstructured":"\u00c1lvarez G.; Varela J.; M\u00e1rquez P.; Gabay M.; Arias Rivas C.E.; Cuchilla K.; Echeverr\u00eda G.A.; Piro O.E.; Chorilli M.; Leal S.M.; Escobar P.; Serna E.; Torres S.; Yaluff G.; Vera de Bilbao N.I.; Gonz\u00e1lez M.; Cerecetto H.; Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity. J Med Chem 2014,57(10),3984-3999","journal-title":"J Med Chem"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1128\/AAC.03814-14","volume":"59","author":"\u00c1lvarez G.","year":"2015","unstructured":"\u00c1lvarez G.; Varela J.; Cruces E.; Fern\u00e1ndez M.; Gabay M.; Leal S.M.; Escobar P.; Sanabria L.; Serna E.; Torres S.; Figueredo Thiel S.J.; Yaluff G.; Vera de Bilbao N.I.; Cerecetto H.; Gonz\u00e1lez M.; Identification of a new amide-containing thiazole as a drug candidate for treatment of Chagas\u2019 disease. Antimicrob Agents Chemother 2015,59(3),1398-1404","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejmech.2014.08.012","volume":"86","author":"Cardoso M.V.","year":"2014","unstructured":"Cardoso M.V.; de Siqueira L.R.; da Silva E.B.; Costa L.B.; Hernandes M.Z.; Rabello M.M.; Ferreira R.S.; da Cruz L.F.; Moreira D.R.; Pereira V.R.; de Castro M.C.; Bernhardt P.V.; Leite A.C.; 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation. Eur J Med Chem 2014,86,48-59","journal-title":"Eur J Med Chem"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejmech.2016.05.050","volume":"121","author":"de Moraes Gomes P.A.T.","year":"2016","unstructured":"de Moraes Gomes P.A.T.; de Oliveira Barbosa M.; Farias Santiago E.; de Oliveira Cardoso M.V.; Capistrano Costa N.T.; Hernandes M.Z.; Moreira D.R.M.; da Silva A.C.; Dos Santos T.A.R.; Pereira V.R.A.; Brayner Dos Santosd F.A.; do Nascimento Pereira G.A.; Ferreira R.S.; Leite A.C.L.; New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi. Eur J Med Chem 2016,121,387-398","journal-title":"Eur J Med Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.bmc.2016.02.027","volume":"24","author":"Costa L.B.","year":"2016","unstructured":"Costa L.B.; Cardoso M.V.; de Oliveira Filho G.B.; de Moraes Gomes P.A.; Esp\u00edndola J.W.; de Jesus Silva T.G.; Torres P.H.; Silva F.P.; Martin J.; de Figueiredo R.C.; Leite A.C.; Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi. Bioorg Med Chem 2016,24(8),1608-1618","journal-title":"Bioorg Med Chem"},{"key":"ref=172","author":"Pages L.B.","year":"2013","unstructured":"Pages L.B.; Pichel J.C.; Menendez R.F.; Esther P.F.; Del Valle S.G.; Maria L.L.; Losana A.M.; Wolfendale M.J.; (Pyrazol-3-yl)-1, 3, 4-thiadiazol-2-amine and (pyrazol-3- yl)-1, 3, 4-thiazol-2-amine compounds; 2013"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"8533","DOI":"10.1021\/jm4012033","volume":"56","author":"Shirude P.S.","year":"2013","unstructured":"Shirude P.S.; Madhavapeddi P.; Naik M.; Murugan K.; Shinde V.; Nandishaiah R.; Bhat J.; Kumar A.; Hameed S.; Holdgate G.; Davies G.; McMiken H.; Hegde N.; Ambady A.; Venkatraman J.; Panda M.; Bandodkar B.; Sambandamurthy V.K.; Read J.A.; Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis. J Med Chem 2013,56(21),8533-8542","journal-title":"J Med Chem"},{"key":"ref=174","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.5b00154","author":"Moraski G.C.","year":"2016","unstructured":"Moraski G.C.; Seeger N.; Miller P.A.; Oliver A.G.; Boshoff H.I.; Cho S.; Arrival of imidazo[2,1- b ]thiazole-5- carboxamides: Potent anti-tuberculosis agents that target QcrB. ACS Infect Dis  acsinfecdis.5b00154. 2016","journal-title":"ACS Infect Dis"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.bmcl.2009.01.083","volume":"19","author":"Smith T.K.","year":"2009","unstructured":"Smith T.K.; Young B.L.; Denton H.; Hughes D.L.; Wagner G.K.; First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness. Bioorg Med Chem Lett 2009,19(6),1749-1752","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1016\/j.bmcl.2009.09.101","volume":"19","author":"Zhang X.","year":"2009","unstructured":"Zhang X.; Li X.; Li D.; Qu G.; Wang J.; Loiseau P.M.; Fan X.; Ionic liquid mediated and promoted eco-friendly preparation of thiazolidinone and pyrimidine nucleoside-thiazolidinone hybrids and their antiparasitic activities. Bioorg Med Chem Lett 2009,19(22),6280-6283","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejmech.2013.05.044","volume":"66","author":"Havrylyuk D.","year":"2013","unstructured":"Havrylyuk D.; Zimenkovsky B.; Vasylenko O.; Day C.W.; Smee D.F.; Grellier P.; Lesyk R.; Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones. Eur J Med Chem 2013,66,228-237","journal-title":"Eur J Med Chem"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejmech.2014.07.103","volume":"85","author":"Havrylyuk D.","year":"2014","unstructured":"Havrylyuk D.; Zimenkovsky B.; Karpenko O.; Grellier P.; Lesyk R.; Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity. Eur J Med Chem 2014,85,245-254","journal-title":"Eur J Med Chem"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1016\/j.tet.2011.04.026","volume":"67","author":"Vintonyak V.V.","year":"2011","unstructured":"Vintonyak V.V.; Warburg K.; Over B.; H\u00fcbel K.; Rauh D.; Waldmann H.; Identification and further development of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B. Tetrahedron 2011,67,6713-6729","journal-title":"Tetrahedron"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/156532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T13:50:25Z","timestamp":1573134625000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/156532\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":179,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,10,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867324666171023163752","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}